We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$53.3B
AUM Growth
+$1.63B
(+3.2%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
17.17%
Holding
3,102
New
155
Increased
2,027
Reduced
775
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$67.7M |
| 2 |
Corteva
CTVA
|
+$33.4M |
| 3 |
TCF
TCF Financial Corporation Common Stock
TCF
|
+$19.3M |
| 4 |
Spotify
SPOT
|
+$15.3M |
| 5 |
Amcor
AMCR
|
+$15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$62.6M |
| 2 |
Apple
AAPL
|
+$51.5M |
| 3 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$29.7M |
| 4 |
NXP Semiconductors
NXPI
|
+$28.9M |
| 5 |
Microsoft
MSFT
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Financials | 15.55% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Industrials | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UCTT
1851
Ultra Clean Holdings
UCTT
$4.01B
| $1.64M | ﹤0.01% |
117,515
+3,560
| +3% | +$45.4K |
|
1852
Editas Medicine
EDIT
$397M
| $1.63M | ﹤0.01% |
65,852
+5,316
| +9% | +$127K |
|
1853
Kosmos Energy
KOS
$1.52B
| $1.63M | ﹤0.01% |
259,834
+73,324
| +39% | +$468K |
|
|
RDUS
1854
DELISTED
Radius Health, Inc.
RDUS
| $1.63M | ﹤0.01% |
66,872
+4,044
| +6% | +$88.4K |
|
1855
PetMed Express
PETS
$41.9M
| $1.63M | ﹤0.01% |
103,678
+13,145
| +15% | +$259K |
|
|
SGMO
1856
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.62M | ﹤0.01% |
150,737
+18,138
| +14% | +$193K |
|
1857
Rush Enterprises Class A
RUSHA
$6.33B
| $1.62M | ﹤0.01% |
99,724
-1,116
| -1% | -$19.5K |
|
1858
Advanced Drainage Systems
WMS
$11B
| $1.61M | ﹤0.01% |
49,202
+1,153
| +2% | +$33.3K |
|
1859
BancFirst
BANF
$3.86B
| $1.61M | ﹤0.01% |
28,869
+808
| +3% | +$44.8K |
|
1860
First Bancorp
FBNC
$2.64B
| $1.6M | ﹤0.01% |
44,010
+609
| +1% | +$22.3K |
|
|
UNT
1861
DELISTED
UNIT Corporation
UNT
| $1.59M | ﹤0.01% |
179,214
-9,473
| -5% | -$110K |
|
|
PGNX
1862
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.59M | ﹤0.01% |
257,328
+16,567
| +7% | +$79.9K |
|
|
ZUO
1863
DELISTED
Zuora, Inc.
ZUO
| $1.58M | ﹤0.01% |
+103,361
| New | +$1.96M |
|
1864
Magnolia Oil & Gas
MGY
$5.97B
| $1.58M | ﹤0.01% |
+136,533
| New | +$1.67M |
|
|
VIVO
1865
DELISTED
Meridian Bioscience Inc
VIVO
| $1.58M | ﹤0.01% |
132,666
+10,067
| +8% | +$121K |
|
1866
Orion
OEC
$390M
| $1.57M | ﹤0.01% |
+73,568
| New | +$1.45M |
|
|
APLS
1867
DELISTED
Apellis Pharmaceuticals
APLS
| $1.57M | ﹤0.01% |
62,050
+15,649
| +34% | +$318K |
|
1868
CEVA Inc
CEVA
$938M
| $1.57M | ﹤0.01% |
64,526
+2,250
| +4% | +$55.2K |
|
|
PINC
1869
DELISTED
Premier
PINC
| $1.57M | ﹤0.01% |
40,170
-16,250
| -29% | -$587K |
|
|
ARQL
1870
DELISTED
Arqule Inc
ARQL
| $1.57M | ﹤0.01% |
142,596
+3,324
| +2% | +$23.1K |
|
1871
Fate Therapeutics
FATE
$291M
| $1.56M | ﹤0.01% |
77,094
-3,126
| -4% | -$56.3K |
|
|
BRSS
1872
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $1.56M | ﹤0.01% |
35,719
+6,629
| +23% | +$282K |
|
1873
Vicor
VICR
$9.89B
| $1.55M | ﹤0.01% |
50,083
+1,378
| +3% | +$44.3K |
|
1874
Verra Mobility
VRRM
$842M
| $1.55M | ﹤0.01% |
+118,492
| New | +$1.58M |
|
|
HAPN
1875
Happen Inc
HAPN
$2.36B
| $1.55M | ﹤0.01% |
94,506
+3,288
| +4% | +$51.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2019 Portfolio in Review
As of Q2 2019, RhumbLine Advisers held 3,102 positions worth $53.3B, up 3.2% from $51.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
RhumbLine Advisers's Q2 2019 filing shows 155 new, 2,027 increased, 775 reduced and 131 closed positions. Its largest new stake was Dow Inc: 1,282,896 shares worth $63.3M. The largest sale was DuPont de Nemours, an estimated $62.6M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2019 buy was Dow Inc: 1,282,896 shares worth $63.3M.
- RhumbLine Advisers added most to TCF Financial Corporation Common Stock in Q2 2019, an estimated $19.3M increase.
- RhumbLine Advisers's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $62.6M.
- RhumbLine Advisers fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $29.7M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $53.3B portfolio in Q2 2019.
- RhumbLine Advisers opened 155 new positions and closed 131 in Q2 2019.
- RhumbLine Advisers's portfolio value rose 3.2% quarter-over-quarter to $53.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.